116 related articles for article (PubMed ID: 986242)
21. Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality.
Karon M; Benedict WF; Rucker N
Cancer Res; 1972 Dec; 32(12):2612-5. PubMed ID: 4674677
[No Abstract] [Full Text] [Related]
22. Enhanced radiation lethality in partially synchronized solid mouse tumors.
Todoroki T; Koike S; Tsunemoto H; Watanabe I
Cancer Res; 1982 Dec; 42(12):5231-5. PubMed ID: 7139626
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine.
Woodcock DM; Fox RM; Cooper IA
Cancer Res; 1979 Apr; 39(4):1418-24. PubMed ID: 421225
[TBL] [Abstract][Full Text] [Related]
24. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
[TBL] [Abstract][Full Text] [Related]
25. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.
Fram RJ; Robichaud N; Bishov SD; Wilson JM
Cancer Res; 1987 Jul; 47(13):3360-5. PubMed ID: 3107809
[TBL] [Abstract][Full Text] [Related]
26. Effect of the interval between exposures to cytarabine on its cytotoxic action on HL-60 myeloid leukemic cells.
Leclerc JM; Momparler RL
Cancer Treat Rep; 1984 Sep; 68(9):1143-8. PubMed ID: 6592037
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
Chou TC; Hutchinson DJ; Schmid FA; Philips FS
Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
[TBL] [Abstract][Full Text] [Related]
29. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
Kong XB; Tong WP; Chou TC
Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
[TBL] [Abstract][Full Text] [Related]
30. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
Smets LA; Homan-Blok J
Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
[TBL] [Abstract][Full Text] [Related]
31. Relationship between aberrant DNA replication and loss of cell viability in Chinese hamster ovary CHO-K1 cells.
Woodcock DM; Adams JK; Cooper IA
Cancer Res; 1982 Nov; 42(11):4744-52. PubMed ID: 7127310
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
Tanaka M; Kimura K; Yoshida S
Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
[TBL] [Abstract][Full Text] [Related]
33. Effect of 1-beta-D-arabinofuranosylcytosine on cell cycle passage time.
Karon M; Shirakawa S
J Natl Cancer Inst; 1970 Nov; 45(5):861-7. PubMed ID: 18605412
[TBL] [Abstract][Full Text] [Related]
34. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
Danhauser LL; Rustum YM
Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
[TBL] [Abstract][Full Text] [Related]
35. Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine.
Boehm TL; Drahovsky D
Cancer Res; 1982 Apr; 42(4):1537-40. PubMed ID: 7060025
[TBL] [Abstract][Full Text] [Related]
36. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
Rauscher F; Cadman E
Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
40. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
Kern DH; Morgan CR; Hildebrand-Zanki SU
Cancer Res; 1988 Jan; 48(1):117-21. PubMed ID: 3334986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
